HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LDP-02

a humanized monoclonal antibody to the alpha4beta7 integrin receptor on leukocytes

Also Known As:

LDP-02 monoclonal antibody; MAb LDP-02; monoclonal antibody LDP-02

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Marshall, J K: 1 article (04/2001)

Related Diseases

1.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/01/2001 - "Millennium (formerly LeukoSite) and Genentech are developing LDP-02, a humanized monoclonal antibody to the alpha4beta7 integrin receptor on leukocytes, for potential use in the treatment of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis [274580]. "
2.	Crohn Disease (Crohn's Disease) 04/01/2001 - "Millennium (formerly LeukoSite) and Genentech are developing LDP-02, a humanized monoclonal antibody to the alpha4beta7 integrin receptor on leukocytes, for potential use in the treatment of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis [274580]. "
3.	Ulcerative Colitis 04/01/2001 - "Millennium (formerly LeukoSite) and Genentech are developing LDP-02, a humanized monoclonal antibody to the alpha4beta7 integrin receptor on leukocytes, for potential use in the treatment of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis [274580]. "

Related Drugs and Biologics

1.	Integrins
2.	Monoclonal Antibodies